Angioedema-type swelling and herpes simplex virus reactivation following hyaluronic acid injection for lip augmentation

Journal of the American Academy of Dermatology

Volumn 65, Issue 1, 2011, Pages

  Dougherty, Alexis L ^a   Rashid, Rashid M ^b   Bangert, Carolyn A ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b University of Texas Health Science Center at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; METHYLPREDNISOLONE; PREDNISONE; VALACICLOVIR;

ANGIONEUROTIC EDEMA; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; ERYTHEMA; FEMALE; HERPES SIMPLEX; HUMAN; LETTER; LIP ANGIOEDEMA; LIP DISEASE; LIP ERYTHEMA; LIP RECONSTRUCTION; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS REACTIVATION;

EID: 79958800584     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.11.043     Document Type: Article

References (6)

1. Dover JS, Carruthers A, Carruthers J, Alam M. Clinical use of Restylane. Skin Therapy Lett 2005;10:5-7.
2. Leonhardt JM, Lawrence N, Narins RS. Angioedema acute hypersensitivity reaction to injectable hyaluronic acid. Dermatol Surg 2005;31:577-9. (Pubitemid 43073202)
3. Bellman B. Immediate and delayed hypersensitivity reactions to Restylane. Aesthetic Surg J 2005;25:489-91. (Pubitemid 41574453)
4. Food and Drug Administration. Restylane: approved labeling. Available from: http://www.fda.gov/cdrh. Accessed on February 22, 2004.
5. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol 2007;57:737-63. (Pubitemid 47553079)
6. Fukui M, Whittlesey K, Metcalfe DD, Dastych J. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid. J Clin Immunol 2000;94:173-8. (Pubitemid 30141745)